SCHEMBL19343830

SCHEMBL19343830

Cc1nc(Cl)c2c(n1)N([C@@H]1O[C@H](CN3CCCC34CCN(C)CC4)[C@H]3OC(C)(C)O[C@H]31)CC2

nearest known ligand 0.37

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ PRMT5 O14744 1/20 0.37
▸ WDR77 Q9BQA1 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19343899 0.91 PRMT5 (0.41) PRMT5WDR77
SCHEMBL19343845 0.79 PRMT5 (0.49) PRMT5WDR77
SCHEMBL19343887 0.77 PIK3R1 (0.35) PRMT5WDR77
SCHEMBL19344128 0.76 PRMT5 (0.55) PRMT5WDR77
SCHEMBL19343829 0.73 PRMT5 (0.50) PRMT5WDR77
SCHEMBL19343880 0.73 PRMT5 (0.58) PRMT5WDR77
SCHEMBL19343825 0.72 PRMT5 (0.61) PRMT5WDR77
SCHEMBL19343823 0.71 PRMT5 (0.48) PRMT5WDR77
SCHEMBL19343817 0.71 PRMT5 (0.57) PRMT5WDR77
SCHEMBL19344424 0.67 PRMT5 (0.39) PRMT5WDR77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3426664-B1 SUBSTITUTED NUCLEOSIDE ANALOGUES FOR USE AS PRMT5 INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2021-06-30 — — EP disclosed
WO-2017153186-A1 SUBSTITUTED NUCLEOSIDE ANALOGUES FOR USE AS PRMT5 INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2017-09-14 — — WO disclosed
Send feedback